My foray into political activism began after reading a letter from The Scientist that responded to an article extolling the wealth of knowledge available to postdocs and implying that poor postdocs should be happy that we have been provided opportunities to learn interesting things.1 That article hit a raw nerve. Written by a fellow postdoc, it made me realize that we have been bred to be compliant, nonconfrontational, and abuse friendly. Wealth in knowledge indeed!Weeks after my response letter
My foray into political activism began after reading a letter from
Weeks after my response letter was published2, the training director at the Burnham Institute said to me: "I don't understand why postdocs feel so powerless. You can help yourselves in so many ways!"
The next day I got a chance to do just that. I was invited by the Joint Steering Committee for Public Policy, a think tank for a coalition of scientific societies, to attend what it calls Capitol Hill Day for postdocs and ...
When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.
View this Issue
In this half-day virtual summit, a series of presentations will explore the scientific, regulatory, and operational factors impacting the use of in vitro NAMs in drug discovery.
In this webinar, scientists will discuss innovations that are unlocking new insights into immunity.
In this webinar, Magdalena Pacewicz will highlight how to use AUC to characterize AAVs as part of ensuring regulatory compliance.
Discover how the latest cancer research models and their applications help scientists pursue breakthrough cancer therapy research.
Chief Business Officer Dr. Rob Burgess Shares How Sino Biological Is Empowering Global Biomedical Research Through Precision, Quality, and Innovation on an Exclusive Segment on Fox Business Network airing on February 1, 2026 at 4:30pm EST
Sino Biological, Inc. has announced the accelerated availability and development of critical research tools to support the global scientific community in combating NiV.
Collaboration will bring next generation orchestration and modular automation to scientists worldwide
The ranking places Refeyn among a cohort of high-growth UK technology firms spanning sectors including the life sciences, energy and sustainability, telecommunications, and digital technology.
